Detalhe da pesquisa
1.
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
CMAJ;
189(24): E819-E827, 2017 Jun 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28630358
2.
A field trial to assess a blood-stage malaria vaccine.
N Engl J Med;
365(11): 1004-13, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21916638
3.
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
J Infect Dis;
207(3): 511-9, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23204168
4.
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Malar J;
12: 29, 2013 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23342996
5.
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Emerg Microbes Infect;
11(1): 2724-2734, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36287714
6.
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
J Clin Invest;
132(10)2022 05 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35316221
7.
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Nat Med;
9(6): 729-35, 2003 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12766765
8.
Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine.
J Infect Dis;
201(4): 580-9, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20078211
9.
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Vaccine X;
1: 100009, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31384731
10.
The dog that did not bark: malaria vaccines without antibodies.
Trends Parasitol;
23(7): 293-6, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17512252
11.
Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
Lancet Infect Dis;
17(8): 854-866, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28606591
12.
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Vaccine;
35(35 Pt A): 4465-4469, 2017 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28647166
13.
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
PLoS One;
12(3): e0173294, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28282396
14.
Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya.
Am J Trop Med Hyg;
75(1): 166-70, 2006 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16837726
15.
Characterization of a human reference standard for antibody to Plasmodium falciparum merozoite surface protein 1(42).
Am J Trop Med Hyg;
72(6): 714-8, 2005 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15964955
16.
Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.
Am J Trop Med Hyg;
73(5): 842-9, 2005 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16282291
17.
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Clin Infect Dis;
39(8): 1095-103, 2004 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15486831
18.
Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
Mol Biochem Parasitol;
128(2): 195-204, 2003 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12742586
19.
Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant.
Expert Rev Vaccines;
2(2): 231-8, 2003 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12899574
20.
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.
Am J Trop Med Hyg;
70(5): 499-509, 2004 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15155981